Thus, in animals with early signs of diabetes-induced neuropathy, C peptide treatment in replacement dosage results in improved peripheral nerve function, as evidenced by increased nerve conduction velocity, increased nerve Na+,K+ ATPase activity, and significant amelioration of nerve structural changes
Three small cohort studies 148,149,150 examined associations between GLP-1RA use and metabolic changes in adults with a diagnosis of schizophrenia and comorbid diabetes and/or obesity on antipsychotics
I'd trace it back to around November 2025, when I went off retatrutide cold turkey for a few months
Blood Sugar Control Enhanced insulin sensitivity and glucose management, especially beneficial for those with type 2 diabetes or prediabetes
Ozempic and Wegovy are GLP-1 receptor agonists that have been shown to cause significant weight loss and work by reducing appetite and increasing feelings of fullness
Our committee can see the promise in tirzepatide but it requires more evidence to be able to evaluate both its clinical and cost effectiveness. A consultation on the Nice guidance has started and will run until 18 July
